Pharming Group N.V. announced it will participate in the 2026 Jefferies Global Healthcare Conference in London from November 16-19, 2026. Key executives, including Interim Co-CEOs Leverne Marsh and Kenneth Lynard, will take part in a fireside chat Q&A session on November 18. The event will be webcast live and available for replay on Pharming's website. This participation highlights Pharming's ongoing engagement with investors and the healthcare community as it advances treatments for rare diseases.
Pharming's participation in the Jefferies Global Healthcare Conference provides context for readers interested in healthcare stocks. For readers following the health sector, here is Pluang's market snapshot as of Nov 11, 2026 13:41 WIB: of 150 priced US health-sector stocks, 50 rose and 97 fell. Notable movers include LQDA at USD 51.40 (+7.37%), BRKR at USD 62.40 (-6.22%), and AHCO at USD 7.75 (+5.37%).
Devia, an AI platform spun out from Visium, has launched to help biopharma companies, CDMOs, and CROs manage GxP quality deviations more efficiently. It automates the entire deviation lifecycle from reporting to root cause analysis and CAPA, reducing...
The Hong Kong Tourism Board is hosting its biggest-ever "Hong Kong WinterFest" from November 18, 2026, to January 5, 2027, featuring three themed winter towns in Central, Tsim Sha Tsui, and Causeway Bay. The event includes immersive light shows, a 22...
The Hong Kong Tourism Board is hosting its biggest-ever Hong Kong WinterFest from November 18, 2026, to January 5, 2027, expanding its Winter Wonderland to three key areas: Central, Tsim Sha Tsui, and Causeway Bay. Each location features unique theme...
ABN AMRO posted a net profit of €940 million in Q3 2026, a 52% increase year-on-year, driven by strong lending, deposits growth, and the acquisition of NIBC. The bank raised its full-year net interest income guidance to over €6.9 billion, supported b...
Artesian Resources Corporation reported Q3 2026 earnings of $0.65 per share, missing the $0.67 estimate and down from $0.68 a year earlier. Revenue rose 4.8% year-over-year to $31.9 million but fell short of the $32.2 million forecast. Net income dec...
